| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/03/2014 | WO2014003008A1 Novel histamine liberator contained in human sweat |
| 01/03/2014 | WO2014002836A1 Egfr-binding peptide |
| 01/03/2014 | WO2014002089A1 Peptides derived from hiv gp41 for treating t-cell mediated pathologies |
| 01/03/2014 | WO2014001820A1 Japanese cedar peptide for preventing or treating allergy |
| 01/03/2014 | WO2014001442A1 Designed ankyrin repeat proteins binding to platelet-derived growth factor |
| 01/03/2014 | WO2014001422A2 Toll-like receptors |
| 01/03/2014 | WO2014000692A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/03/2014 | WO2014000042A1 COMPOSITIONS AND METHODS FOR MODIFYING TGF-β FAMILY LIGANDS |
| 01/03/2014 | WO2013167750A3 Method for diagnosis and treatment of prolactin associated disorders |
| 01/03/2014 | WO2013049234A3 Dual function proteins for treating metabolic disorders |
| 01/03/2014 | WO2012168680A8 Pharmaceutical preparation comprising recombinant fsh |
| 01/03/2014 | WO2012166626A8 Reagents and methods for treating dental disease |
| 01/03/2014 | CA2877986A1 Ctla4 fusion proteins for the treatment of diabetes |
| 01/03/2014 | CA2877968A1 Methods and compositions for natural killer cells |
| 01/03/2014 | CA2877886A1 Targeted therapeutics |
| 01/03/2014 | CA2877584A1 Designed ankyrin repeat proteins binding to platelet-derived growth factor |
| 01/03/2014 | CA2840683A1 Axmi277 nematode toxin and methods for its use |
| 01/03/2014 | CA2803566A1 Syringe |
| 01/02/2014 | US20140007303 Use of recombinant polypeptides from the genus lupinus as antimicrobial or insecticidal on plants |
| 01/02/2014 | US20140007292 Novel Insecticidal Proteins and Methods for Their Use |
| 01/02/2014 | US20140007265 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 01/02/2014 | US20140005365 Antibody to a mutant g-csf for diagnosis of cancer |
| 01/02/2014 | US20140005363 Protein hydrolyzate and processes for the production thereof |
| 01/02/2014 | US20140005362 Recombinant cytotoxin as well as a method of producing it |
| 01/02/2014 | US20140005361 FC-Interferon-Beta Fusion Proteins |
| 01/02/2014 | US20140005360 Polypeptides and Immunizing Compositions Containing Gram Positive Polypeptides and Methods of Use |
| 01/02/2014 | US20140005358 Natriuretic polypeptides |
| 01/02/2014 | US20140005356 Method for in vivo residue-specific DOPA incorporation into mussel adhesive proteins |
| 01/02/2014 | US20140005126 Scaffold peptides |
| 01/02/2014 | US20140005125 Designed ankyrin repeat proteins binding to platelet-derived growth factor |
| 01/02/2014 | US20140005120 Activity Enhancer for Anticancer Agent |
| 01/02/2014 | US20140005109 Therapeutic Compositions and Methods for Disorders Associated with Neuronal Degeneration |
| 01/02/2014 | US20140005107 Apolipoprotein aiv as an antidiabetic peptide |
| 01/02/2014 | US20140005106 Method for administering glp-1 molecules |
| 01/02/2014 | US20140005098 Igfbp-3 derivatives and uses thereof |
| 01/02/2014 | US20140005097 Bioactive peptides and methods of using same |
| 01/02/2014 | US20140005096 Methods of treating inflammation |
| 01/02/2014 | US20140004603 Urocortin-iii and uses thereof |
| 01/02/2014 | US20140004535 Mutant smoothened and methods of using the same |
| 01/02/2014 | US20140004532 Nucleic Acids Encoding a Mammalian Raptor Polypeptide and Uses Therefor |
| 01/02/2014 | US20140004181 Compositions and methods for exosome targeted expression |
| 01/02/2014 | US20140004175 Angiopoietin derived peptides |
| 01/02/2014 | US20140004151 Antigens and Epitopes Derived From Mycobacterium Tuberculosis |
| 01/02/2014 | US20140004146 Method for producing virus-like particle by using drosophila cell and applications thereof |
| 01/02/2014 | US20140004145 Purification of virus like particles |
| 01/02/2014 | US20140004143 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 01/02/2014 | US20140004141 Methods And Compositions Of Protein Antigens For The Diagnosis And Treatment Of Toxoplasma Gondii Infections And Toxoplasmosis |
| 01/02/2014 | US20140004139 Serologic correlates of protection against bacillis anthracis infection |
| 01/02/2014 | US20140004136 Phosphorylated derivatives of a u1-70k peptide and their use in the treatment of autoimmune pathologies |
| 01/02/2014 | US20140004129 Novel Polypeptides Involved in Immune Response |
| 01/02/2014 | US20140004113 Defensin-antigen fusion proteins |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/02/2014 | US20140004089 Chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/02/2014 | US20140004076 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases |
| 01/02/2014 | US20140004047 Methods, compositions and kits for modulating trans-differentiation of muscle satellite cells |
| 01/01/2014 | EP2679683A2 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same |
| 01/01/2014 | EP2679599A1 Antibodies directed to Angiopoietin-1 and Angiopoietin-2 and use thereof |
| 01/01/2014 | EP2679598A1 T cell receptors and related materials and methods of use |
| 01/01/2014 | EP2679597A1 Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| 01/01/2014 | EP2679596A1 HIV-1 env glycoprotein variant |
| 01/01/2014 | EP2679246A2 Novel therapeutical tools and methods for treating blindness |
| 01/01/2014 | EP2679235A2 Peptides and related molecules that modulate nerve growth factor activity |
| 01/01/2014 | EP2679234A2 Binding proteins that bind to human FGFR1C, human beta-klotho and both human FGFR1C and human beta-klotho |
| 01/01/2014 | EP2678452A2 Exogenous internal positive control |
| 01/01/2014 | EP2678426A1 Proteins for biocontrol of plant pathogenic fungi |
| 01/01/2014 | EP2678361A2 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use |
| 01/01/2014 | EP2678355A1 Novel superactive il-33 fragments, and uses thereof |
| 01/01/2014 | EP2678354A1 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes |
| 01/01/2014 | EP2678353A1 Igfbp-3 derivatives and uses thereof |
| 01/01/2014 | EP2678352A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/01/2014 | EP2678351A1 Rapid selection method for hiv gp-120 variants |
| 01/01/2014 | EP2678001A2 Polymer conjugated protein micelles |
| 01/01/2014 | EP2677863A1 Modified pig islets for diabetes treatment |
| 01/01/2014 | EP1682573B1 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 01/01/2014 | CN103492573A Plants having enhanced yield-related traits and producing methods thereof |
| 01/01/2014 | CN103492562A Methods and materials for enhancing functional protein expression in bacteria |
| 01/01/2014 | CN103492411A Mutant interleukin-2 polypeptides |
| 01/01/2014 | CN103492410A Bluetongue virus recombinant vaccines and uses thereof |
| 01/01/2014 | CN103492408A Method for isolating osteopontin using feeds containing cmp or casein species |
| 01/01/2014 | CN103491984A Radiolabled her2 binding peptides |
| 01/01/2014 | CN103491979A Malaria vaccines based on pre-erythrocytic antigens from p. falciparum |
| 01/01/2014 | CN103491974A Method for increasing neprilysin expression and activity |
| 01/01/2014 | CN103491799A Aerated food products |
| 01/01/2014 | CN103484942A Thermophilic streptomyces hygroscopicus cDNA library construction, and expression and expression methods of two greenhouse farmer's lungpathopoiesia antigen polypeptides |
| 01/01/2014 | CN103484479A Latcripin-4 gene fragment of mushroom C91-3 strain, encoding protein and preparation method thereof |
| 01/01/2014 | CN103484478A Latcripin-18 gene fragment of mushroom C91-3 strain, encoding protein and preparation method thereof |
| 01/01/2014 | CN103484477A Latcripin-15 gene segment of mushroom C91-3 strain, coded protein and preparation method |
| 01/01/2014 | CN103484476A Latcripin-13 gene segment of mushroom C91-3 strain, coded protein and preparation method |
| 01/01/2014 | CN103484474A Gene SLF participating in controlling intra-specific and inter-species reproductive disorder of solanaceae plants and application of gene SLF |
| 01/01/2014 | CN103484473A High-lysine/protein gene GhLRP and application thereof |
| 01/01/2014 | CN103484472A Rice lateral root formation control gene OsHK1 and coded protein thereof |
| 01/01/2014 | CN103484471A HEGF (human epidermal growth factor) nucleotide sequence and colibacillus expression vector |
| 01/01/2014 | CN103484470A Tubular worm galactose lectin and preparing method thereof |
| 01/01/2014 | CN103484469A Diamondback moth antibacterial peptide defensin, preparation method and application thereof |
| 01/01/2014 | CN103484468A Diamondback moth peptidoglycan recognition protein, preparation method and application thereof |
| 01/01/2014 | CN103484467A Diamondback moth cecropin 3, preparation method and application thereof |
| 01/01/2014 | CN103484466A Diamondback moth antibacterial peptide moricin, preparation method and application thereof |
| 01/01/2014 | CN103483446A Broad spectrum neutralization monoclonal antibodies or antigen binding fragments thereof of anti-HPV L2 protein, and applications thereof |
| 01/01/2014 | CN103483445A Preparation methods and applications of benzylpenicilloic acid artificial antigen and benzylpenicilloic acid artificial antibody |
| 01/01/2014 | CN103483444A Antibody for detecting and determining berberine, and method and kit thereof |